|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646758591 |
003 |
OCoLC |
005 |
20231117033249.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
750720s1976 nyu ob 001 0 eng d |
010 |
|
|
|z 59013823
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d N$T
|d IDEBK
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d YDXCP
|d OCLCQ
|d DEBBG
|d OTZ
|d LEAUB
|d VLY
|d OCLCO
|d INARC
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 297547402
|a 1162395369
|a 1397389195
|
020 |
|
|
|a 9780080564340
|q (electronic bk.)
|
020 |
|
|
|a 0080564348
|q (electronic bk.)
|
020 |
|
|
|a 0120026201
|q (electronic bk.)
|
020 |
|
|
|a 9780120026203
|q (electronic bk.)
|
020 |
|
|
|a 9786611738143
|
020 |
|
|
|a 6611738142
|
035 |
|
|
|a (OCoLC)646758591
|z (OCoLC)297547402
|z (OCoLC)1162395369
|z (OCoLC)1397389195
|
050 |
|
4 |
|a QR1
|b .A3820 1976eb
|
072 |
|
7 |
|a MED
|x 052000
|2 bisacsh
|
082 |
0 |
4 |
|a 660.6/2
|2 22
|
245 |
0 |
0 |
|a Advances in applied microbiology
|n Volume 20 /
|c edited by D. Perlman.
|
246 |
3 |
0 |
|a Applied microbiology
|
260 |
|
|
|a New York :
|b Academic Press,
|c 1976.
|
300 |
|
|
|a 1 online resource (ix, 381 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in applied microbiology ;
|v 20
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Advances in Applied Microbiology, Volume 20; Copyright Page; Contents; List of Contributors; Chapter 1. The Current Status of Pertussis Vaccine: An Overview; Text; Chapter 2. Biologically Active Components and Properties of Bordetella pertussis; I. Introduction; II. Sensitization to Histamine; III. �-Adrenergic Blockade; IV. Lymphocytosis-Promoting Factor; V. Adjuvanticity; VI. Lipopolysaccharide Endotoxin; VII. Heat-Labile Toxin; VIII. Hemagglutinin; IX. Mitogenicity for Lymphocytes; X. Interrelationships between Biological Activities; XI. Pathogenesis of Pertussis; References
|
505 |
8 |
|
|a Chapter 3. Role of the Genetics and Physiology of Bordetella pertussis in the Production of Vaccine and the Study of Host-Parasite Relationships in PertussisI. Introduction; II. Genetics; III. Physiology; References; Chapter 4. Problems Associated with the Development and Clinical Testing of an Improved Pertussis Vaccine; I. Do We Need an Improved Pertussis Vaccine?; II. Why Don't We Have an Improved or Fully Acceptable Pertussis Vaccine Now?; III. Where Do We Go From Here with the Development of an Improved Pertussis Vaccine?
|
505 |
8 |
|
|a IV. Can We Really Expect to Get New Pertussis Vaccines Approved, Marketed, and in General Distribution?References; Chapter 5. Problems Associated with the Control Testing of Pertussis Vaccine; I. Introduction; II. Colonial Variation in Bordetella pertussis; III. Opacity Standards; IV. Potency Assay; V. Role of Adjuvant; VI. Agglutinins; VII. Toxicity; VIII. Summary; References; Chapter 6. Vinegar: Its History and Development; I. Introduction; II. In the Beginning; III. Nonfood Uses of Vinegar through the Centuries; IV. Vinegar in Food Processing; V. Production Methods
|
505 |
8 |
|
|a VI. Major Types of VinegarVII. The Industry; VIII. Microbiology of Vinegar Production; IX. Mechanism of the Biological Conversion of Ethanol to Acetic Acid; X. Composition of Vinegar; XI. Summary; References; Chapter 7. Microbial Rennets; I. Introduction; II. Microbial Rennets from Endothla parasitica. Mucor miehei, and Mucor pusillus var. Lindt; III. Screening for New Microbial Rennets; IV. Conclusions; References; Chapter 8. Biosynthesis of Cephalosporins; I. Introduction; II. Occurrence of Cephalosporins and Related Metabolites; III. Genetic Studies and Strain Improvement
|
505 |
8 |
|
|a IV. FermentationV. Biosynthesis; VI. Enzymes Related to Cephalosporin Metabolism; VII. Conclusions; References; Chapter 9. Preparation of Pharmaceutical Compounds by Immobilized Enzymes and Cells; I. Introduction; II. Penicillins; III Cephalosporins; IV. Amino Acids; V. Other Products; VI. Concluding Remarks; References; Chapter 10. Cytotoxic and Antitumor Antibiotics Produced by Microorganisms; I. Introduction; II. Antibiotics and Their Synonyms; III. List of Tumors; References; SUBJECT INDEX; CONTENTS OF PREVIOUS VOLUMES
|
520 |
|
|
|a ADVANCES IN APPLIED MICROBIOLOGY VOL 20.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Microbiology
|x Research.
|
650 |
|
0 |
|a Microbiology.
|
650 |
|
6 |
|a Microbiologie.
|0 (CaQQLa)201-0003856
|
650 |
|
7 |
|a microbiology.
|2 aat
|0 (CStmoGRI)aat300054469
|
650 |
|
7 |
|a MEDICAL
|x Microbiology.
|2 bisacsh
|
650 |
|
7 |
|a Microbiology
|2 fast
|0 (OCoLC)fst01019576
|
650 |
|
7 |
|a Microbiology
|x Research
|2 fast
|0 (OCoLC)fst01019590
|
650 |
|
7 |
|a Microbiologie industrielle.
|2 ram
|
700 |
1 |
|
|a Perlman, D.,
|d 1920-
|
776 |
0 |
8 |
|i Print version:
|t Advances in applied microbiology.
|d New York : Academic Press, 1976
|w (DLC) 59013823
|
830 |
|
0 |
|a Advances in applied microbiology ;
|v 20.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120026203
|z Texto completo
|